Medifoxamine

Medifoxamine

Gene therapy
Clinical data
Physiological data
Legal status
Pharmacokinetic data
Identifiers
IUPAC name N,N-dimethyl-2,2-bis(phenoxy)ethanamine
CAS Number	32359-34-5
PubChem Template:Abbreviation	36109
Chemical and physical data
Formula	C16H19NO2
Molar mass	257.328 g/mol
3D model (JSmol)	Interactive image
SMILES CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2

WikiDoc Resources for Medifoxamine
Articles
Most recent articles on Medifoxamine Most cited articles on Medifoxamine Review articles on Medifoxamine Articles on Medifoxamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Medifoxamine Images of Medifoxamine Photos of Medifoxamine Podcasts & MP3s on Medifoxamine Videos on Medifoxamine
Evidence Based Medicine
Cochrane Collaboration on Medifoxamine Bandolier on Medifoxamine TRIP on Medifoxamine
Clinical Trials
Ongoing Trials on Medifoxamine at Clinical Trials.gov Trial results on Medifoxamine Clinical Trials on Medifoxamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Medifoxamine NICE Guidance on Medifoxamine NHS PRODIGY Guidance FDA on Medifoxamine CDC on Medifoxamine
Books
Books on Medifoxamine
News
Medifoxamine in the news Be alerted to news on Medifoxamine News trends on Medifoxamine
Commentary
Blogs on Medifoxamine
Definitions
Definitions of Medifoxamine
Patient Resources / Community
Patient resources on Medifoxamine Discussion groups on Medifoxamine Patient Handouts on Medifoxamine Directions to Hospitals Treating Medifoxamine Risk calculators and risk factors for Medifoxamine
Healthcare Provider Resources
Symptoms of Medifoxamine Causes & Risk Factors for Medifoxamine Diagnostic studies for Medifoxamine Treatment of Medifoxamine
Continuing Medical Education (CME)
CME Programs on Medifoxamine
International
Medifoxamine en Espanol Medifoxamine en Francais
Business
Medifoxamine in the Marketplace Patents on Medifoxamine
Experimental / Informatics
List of terms related to Medifoxamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Medifoxamine is an antidepressant drug which inhibits the reuptake of dopamine and acts as an agonist at the 5HT_2A and 5HT_2C receptors. It is used mainly in France.